Rongyuan Zhuang

2PUBLICATIONS
12CO-AUTHORS
Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 13, 2022
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial.

Zhi-Ming Wang, Rong-Yuan Zhuang, Xi Guo

Pageof 1